FBT icon

First Trust NYSE Arca Biotechnology Index Fund

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 100%
Negative

Neutral
Seeking Alpha
5 days ago
Can Forgotten Biotech Break Out?
After a 50%+ run from lows last April through highs in mid-January, the Biotech group has been trending sideways over the last few months. Biotech hasn't garnered much attention lately, with all the coverage of the Iran War and the AI Doom trade that's been taking down software stocks even as AI infrastructure stocks continue to surge.
Can Forgotten Biotech Break Out?
Neutral
Zacks Investment Research
1 month ago
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
A smart beta exchange traded fund, the First Trust NYSE Arca Biotechnology ETF (FBT) debuted on 06/19/2006, and offers broad exposure to the Health Care ETFs category of the market.
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
Neutral
Zacks Investment Research
1 month ago
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
The First Trust NYSE Arca Biotechnology ETF (FBT) was launched on June 19, 2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of the equity market.
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
Positive
24/7 Wall Street
3 months ago
Biotech Could Be One of 2026's Biggest Winners, and This ETF Is Perfectly Positioned
Biotech investors spent years waiting for the sector to recover from its brutal 2021 peak.
Biotech Could Be One of 2026's Biggest Winners, and This ETF Is Perfectly Positioned
Neutral
Zacks Investment Research
3 months ago
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
The First Trust NYSE Arca Biotechnology ETF (FBT) was launched on 06/19/2006, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
Neutral
Zacks Investment Research
3 months ago
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
The First Trust NYSE Arca Biotechnology ETF (FBT) was launched on June 19, 2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of the equity market.
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
Positive
Zacks Investment Research
4 months ago
2 ETFs to Watch for Outsized Volume on Biotechnology Stocks
Biotech ETFs PBE and FBT saw trading volumes soar to over four times their averages, signaling rising interest amid a down day for major indexes.
2 ETFs to Watch for Outsized Volume on Biotechnology Stocks
Positive
Seeking Alpha
5 months ago
Investing In Health Stocks - How Policy Clarity Is Opening Doors
The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. Healthcare trades at historical valuation discounts across multiple metrics.
Investing In Health Stocks - How Policy Clarity Is Opening Doors
Neutral
Zacks Investment Research
5 months ago
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
Making its debut on 06/19/2006, smart beta exchange traded fund First Trust NYSE Arca Biotechnology ETF (FBT) provides investors broad exposure to the Health Care ETFs category of the market.
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
Neutral
Zacks Investment Research
5 months ago
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the First Trust NYSE Arca Biotechnology ETF (FBT), a passively managed exchange traded fund launched on June 19, 2006.
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?